When antidepressants called selective serotonin reuptake inhibitors, or SSRIs, burst onto the scene in the 1980s, they provided much-needed relief for millions suffering from mood disorders like depression. However, even as SSRIs have become one of the most commonly prescribed drugs in the world, the details of how they interact with the brain remain somewhat mysterious.

Recently a research team at The Rockefeller University made strides in unraveling the brain circuitry in mice that responds to SSRIs, and pinpointed the cells where the response starts, information that could be used to develop more-effective treatments. Their work was published in Neuron.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
Sign up to receive a free weekly opinions recap from our community of experts.
Privacy Policy